Scholarlink

Immune checkpoint inhibitors (ICI) have revolutionized the treatment of various malignancies. However, these therapies are associated with immune-related adverse events (irAEs), which can significantly impact patient management. Pancreatic irAEs are rare and may have a varied spectrum of clinical presentation as is demonstrated in the case series to follow.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pancreatitis Related to Immune Checkpoint Inhibitor Therapy

  • 章节

  • 发表日期：

    2025年

查看全文
  • Sidra Naz,
  • Sireesha Yedururi,
  • Yinghong Wang,
  • Suresh Chari,
  • Anusha S. Thomas

摘要

Immune checkpoint inhibitors (ICI) have revolutionized the treatment of various malignancies. However, these therapies are associated with immune-related adverse events (irAEs), which can significantly impact patient management. Pancreatic irAEs are rare and may have a varied spectrum of clinical presentation as is demonstrated in the case series to follow.